Investigating the human protein-host protein interactome of SARS-CoV-2 infection in the small intestine
- PMID: 33244381
- PMCID: PMC7682973
Investigating the human protein-host protein interactome of SARS-CoV-2 infection in the small intestine
Abstract
Aim: The present study aimed to identify human protein-host protein interactions of SARS-CoV-2 infection in the small intestine to discern the potential mechanisms and gain insights into the associated biomarkers and treatment strategies.
Background: Deciphering the tissue and organ interactions of the SARS-CoV-2 infection can be important to discern the potential underlying mechanisms. In the present study, we investigated the human protein-host protein interactions in the small intestine.
Methods: Public databases and published works were used to collect data related to small intestine tissue and SARS-CoV-2 infection. We constructed a human protein-protein interaction (PPI) network and showed interactions of host proteins in the small intestine. Associated modules, biological processes, functional pathways, regulatory transcription factors, disease ontology categories, and possible drug candidates for therapeutic targets were identified.
Results: Thirteen primary protein neighbors were found for the SARS-CoV-2 receptor ACE2. ACE2 and its four partners were observed in a highly clustered module; moreover, 8 host proteins belonged to this module. The protein digestion and absorption as a significant pathway was highlighted with enriched genes of ACE2, MEP1A, MEP1B, DPP4, and XPNPEP2. The HNF4A, HNF1A, and HNF1B transcription factors were found to be regulating the expression of ACE2. A significant association with 12 diseases was deciphered and 116 drug-target interactions were identified.
Conclusion: The protein-host protein interactome revealed the important elements and interactions for SARS-CoV-2 infection in the small intestine, which can be useful in clarifying the mechanisms of gastrointestinal symptoms and inflammation. The results suggest that antiviral targeting of these interactions may improve the condition of COVID-19 patients.
Keywords: Drug targets; Interactome; Protein interaction network; Regulatory network; SARS-CoV-2; Small intestine.
©2020 RIGLD, Research Institute for Gastroenterology and Liver Diseases.
Figures







Similar articles
-
SARS-CoV-2/human interactome reveals ACE2 locus crosstalk with the immune regulatory network in the host.Pathog Dis. 2021 Feb 19;79(2):ftab005. doi: 10.1093/femspd/ftab005. Pathog Dis. 2021. PMID: 33469663 Free PMC article.
-
COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection.J Transl Med. 2020 Jun 10;18(1):233. doi: 10.1186/s12967-020-02405-w. J Transl Med. 2020. PMID: 32522207 Free PMC article.
-
ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors.J Clin Med. 2020 Nov 21;9(11):3743. doi: 10.3390/jcm9113743. J Clin Med. 2020. PMID: 33233425 Free PMC article.
-
Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-O-gallate (EGCG) in SARS-CoV-2 infection: Major interactions with host/virus proteases.Phytomed Plus. 2023 Feb;3(1):100402. doi: 10.1016/j.phyplu.2022.100402. Epub 2022 Dec 30. Phytomed Plus. 2023. PMID: 36597465 Free PMC article. Review.
-
Host-Cell Surface Binding Targets in SARS-CoV-2 for Drug Design.Curr Pharm Des. 2022;28(45):3583-3591. doi: 10.2174/1381612829666221123111849. Curr Pharm Des. 2022. PMID: 36420875 Review.
Cited by
-
Evaluation of serum and urine biomarkers for severe COVID-19.Front Med (Lausanne). 2024 Mar 6;11:1357659. doi: 10.3389/fmed.2024.1357659. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38510452 Free PMC article.
-
Potential therapeutic options for COVID-19: an update on current evidence.Eur J Med Res. 2022 Jan 13;27(1):6. doi: 10.1186/s40001-021-00626-3. Eur J Med Res. 2022. PMID: 35027080 Free PMC article. Review.
-
Comprehensive proteomic analysis of HCoV-OC43 virions and virus-modulated extracellular vesicles.J Virol. 2024 Jul 23;98(7):e0085024. doi: 10.1128/jvi.00850-24. Epub 2024 Jul 2. J Virol. 2024. PMID: 38953378 Free PMC article.
-
Proteomic profiling identifies biomarkers of COVID-19 severity.Heliyon. 2023 Dec 9;10(1):e23320. doi: 10.1016/j.heliyon.2023.e23320. eCollection 2024 Jan 15. Heliyon. 2023. PMID: 38163173 Free PMC article.
-
Survival-based CRISPR genetic screens across a panel of permissive cell lines identify common and cell-specific SARS-CoV-2 host factors.Heliyon. 2023 Jan;9(1):e12744. doi: 10.1016/j.heliyon.2022.e12744. Epub 2022 Dec 30. Heliyon. 2023. PMID: 36597481 Free PMC article.
References
-
- Cao W. Clinical features and laboratory inspection of novel coronavirus pneumonia (COVID-19) in Xiangyang, Hubei. medRxiv. 2020
-
- Fang Z, Yi F, Wu K, Lai K, Sun X, Zhong N, et al. Clinical characteristics of 2019 coronavirus pneumonia (COVID-19): an updated systematic review. MedRxiv. 2020
LinkOut - more resources
Full Text Sources
Miscellaneous